Minerva Neurosciences (NERV)
(Delayed Data from NSDQ)
$2.82 USD
-0.03 (-1.17%)
Updated Sep 19, 2024 03:58 PM ET
After-Market: $2.86 +0.04 (1.54%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for Minerva Neurosciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -30.01 | -32.11 | -49.91 | 1.94 | -72.18 |
Depreciation/Amortization & Depletion | 0.03 | 0.01 | 0.10 | 0.09 | -0.60 |
Net Change from Assets/Liabilities | 4.94 | -4.06 | 0.26 | -45.56 | 3.43 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 10.25 | 11.52 | 24.94 | 9.70 | 25.92 |
Net Cash From Operating Activities | -14.78 | -24.65 | -24.60 | -33.82 | -43.43 |
Property & Equipment | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 24.53 | 14.08 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | -0.02 | 0.00 | 24.53 | 14.08 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 20.00 | 0.00 | 0.00 | 13.69 | 0.52 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.40 | 0.00 | 60.00 | -0.46 | 0.00 |
Net Cash from Financing Activities | 19.60 | 0.00 | 60.00 | 13.24 | 0.52 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 4.82 | -24.66 | 35.40 | 3.94 | -28.82 |
Cash at Beginning of Period | 36.19 | 60.86 | 25.46 | 21.51 | 50.33 |
Cash at End of Period | 41.01 | 36.19 | 60.86 | 25.46 | 21.51 |
Diluted Net EPS | -4.61 | -6.01 | -9.36 | 0.40 | -14.80 |
Fiscal Year End for Minerva Neurosciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -16.80 | -8.57 | -30.01 | -20.98 | -13.16 |
Depreciation/Amortization & Depletion | 0.02 | 0.01 | 0.03 | 0.02 | 0.02 |
Net Change from Assets/Liabilities | 1.42 | -0.22 | 4.94 | 4.72 | 4.17 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 5.33 | 2.69 | 10.25 | 7.45 | 4.99 |
Net Cash From Operating Activities | -10.03 | -6.09 | -14.78 | -8.79 | -3.99 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 20.00 | 20.00 | 20.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -0.40 | -0.40 | -0.31 |
Net Cash from Financing Activities | 0.00 | 0.00 | 19.60 | 19.60 | 19.69 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -10.03 | -6.09 | 4.82 | 10.81 | 15.70 |
Cash at Beginning of Period | 41.01 | 41.01 | 36.19 | 36.19 | 36.19 |
Cash at End of Period | 30.98 | 34.92 | 41.01 | 47.00 | 51.90 |
Diluted Net EPS | -1.09 | -1.13 | -1.15 | -1.03 | -1.12 |